USD 16.17
Price
-1.14
(-6.59%)
Day Change
|
|
---|
MYGN, ファンダメンタルスコアはnot good (ファンダメンタル = 46) そしてテクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
Deepscope 分析 |
|
44% |
In Recommendations? | Not in any sections |
Select Rate | 0.00 From 30 days period |
Watch Rate | 0.00 From 30 days period |
Social Score | 2 |
Magic Formula Rank by ROA |
N/A
|
Magic Formula Rank by ROE |
N/A
|
Magic Formula Rank by ROIC |
N/A
|
Price | 16.17 |
PBV / Sector |
2.17 / -4.87
|
Earning Per Share | -1.74 |
PE / Sector |
N/A / 45.03
|
PEG or PE/Growth / Sector |
1.40 / 1.96
|
Average 1M Daily Value |
17.14 M
GREAT
|
Average 1W Daily Value |
19.18 M
GREAT
|
Timing Factors |
|
28% |
Financial Health |
|
45% |
ポイントになる統計 |
|
60% |
配当 |
|
37% |
登録情報 |
Analyze Date | 2024-11-12 23:01:31 |
Symbol | MYGN |
Name | MYRIAD GENETICS INC |
Sector | Healthcare >> Diagnostics & Research |
Market | NASDAQ |
Listed Shares | 90.82 M |
Par Value | N/A |
Calculated From | Quarter |
Sign | N/A |
Market Cap (M.USD) / Sector Average | 1,581.18 / 36,903.53 |
ニュース |
Estimation Consensus | See at WSJ.com |
Full details | See at WSJ.com |
Chart | See in Chart feature |
News | See at Yahoo Finance |